US 10975158
CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 10975158 (CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities) held by The Regents of the University of California expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K38/212, A61K38/215